We invite you to Advanced Industrial Bioprocessing. We are planning a 5-day professional short course on Aug 3 – 7, 2020 at UMass Lowell. The course will be taught by industry professionals from BMS, Pfizer, MilliporeSigma, and UMass experts.
The trainees will learn key principles and concepts of industrial bioprocessing of protein, cell and gene therapies. The course covers recent technologies and practices of upstream, downstream and analytical bioprocessing technologies. In addition, FDA initiatives of PAT (Process Analytical Technology), Quality by Design, and Emerging Technology will be covered. The course consists of 7 modules.
Module 1, Upstream Bioprocessing
Module 2, Downstream Bioprocessing
Module 3, Analytical Technology in Bioprocessing
Module 4, Cell Therapy & Bioprocessing
Module 5, Gene Therapy & Bioprocessing
Module 6, Regulatory, QbD, and PAT in Bioprocessing
Module 7, Big data Analytics for Biopharmaceutical
The tentative schedule for the biomanufacturing short course can be found here.
Who can benefit from this professional course
Individuals that are involved in manufacturing, product and process development, regulatory, QA/QC and of biotech therapeutics. Attendees from academia and regulatory agencies may also benefit depending on their areas of interest and level of experience.